VolitionRx anticipates first DETECSEPS patient in September as Q1 revenue rises to about $1M
VolitionRx Limited · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $2.65
+47% in 7d after detection
Post-detection moves
1h
—
1d
+14%
3d
+25%
7d
+47%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS